Lithium Dose Adjustment from 0.7 to >0.8 mEq/L
Increase the daily lithium dose by approximately 150-300 mg (5-10 mmol) to raise the serum level from 0.7 to above 0.8 mEq/L, with the exact increment depending on current total daily dose and patient age.
Dosing Strategy
The relationship between lithium dose and serum level is generally linear but varies by individual factors. Based on FDA labeling and clinical pharmacology data:
- For acute mania maintenance: The FDA label indicates that 300 mg TID or QID (900-1200 mg/day total) typically maintains levels of 0.6-1.2 mEq/L 1
- Current level of 0.7 mEq/L: This is at the lower end of the therapeutic range and requires upward adjustment
Practical Dose Increase Algorithm
If current dose is ≤900 mg/day:
- Increase by 300 mg daily (add one 300 mg dose)
- This typically raises serum level by approximately 0.15-0.25 mEq/L
If current dose is >900 mg/day:
- Increase by 150-300 mg daily
- Smaller increments are safer at higher baseline doses
For patients ≥60 years old:
- Use the lower end of dose increases (150 mg increments)
- Elderly patients are more sensitive to lithium and exhibit toxicity at lower levels 1
Target Level Considerations
The evidence supports different target ranges based on clinical indication:
- For acute mania: 0.8-1.0 mEq/L is appropriate 2
- For maintenance/prophylaxis: 0.6-0.8 mEq/L is generally adequate 3, 4
- For patients ≥50 years: Target 0.5-0.6 mEq/L to minimize toxicity risk 2
Your target of >0.8 mEq/L should only be pursued if treating acute mania or if the patient has demonstrated insufficient response at lower levels with good tolerance 4. For most maintenance situations, 0.7 mEq/L is actually adequate.
Monitoring Protocol
- Check serum level 5-7 days after dose adjustment (allows 4-5 half-lives to reach steady state, given lithium's 18-36 hour half-life) 3
- Draw blood exactly 12 hours post-dose for accurate interpretation 1, 5
- If drawn at other times, the measured level will be inaccurate—consider using estimation equations 5
Critical Safety Points
Toxicity risk increases substantially above 1.5 mEq/L 1. Early signs include:
- Diarrhea, vomiting, drowsiness
- Muscular weakness, lack of coordination
- These can occur even below 2.0 mEq/L
Do not exceed 2.0 mEq/L during acute treatment 1.
Avoid concurrent medications that reduce lithium clearance:
- NSAIDs (including COX-2 inhibitors)
- ACE inhibitors
- Diuretics These can precipitate toxicity even at previously stable doses 6
Age-Specific Cautions
For patients ≥60 years, reconsider whether >0.8 mEq/L is truly necessary. The ISBD/IGSLI consensus recommends 0.4-0.8 mEq/L for ages 60-79 and 0.4-0.7 mEq/L for ≥80 years 4, 7. Elderly patients develop neurotoxicity at levels tolerated by younger patients 1.